Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis
- 31 August 2004
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 3 (3) , 179-183
- https://doi.org/10.1016/j.jcf.2004.04.005
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scoresEuropean Journal of Radiology, 2001
- Cystic Fibrosis: CT Assessment of Lung Involvement in Children and AdultsRadiology, 1999
- Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung diseaseClinical and Experimental Immunology, 1999
- The innate immune system in cystic fibrosis lung diseaseJournal of Clinical Investigation, 1999
- Antineutrophil Cytoplasmic Autoantibodies (ANCA) in Children with Cystic FibrosisJournal of Autoimmunity, 1998
- Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitisClinical and Experimental Immunology, 1996
- High levels of complement‐activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung functionPediatric Pulmonology, 1995
- ANCA and associated diseases: immunodiagnostic and pathogenetic aspectsClinical and Experimental Immunology, 1993
- Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.Thorax, 1992
- An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA)Journal of Immunological Methods, 1990